Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasma cell | 12 studies | 30% ± 14% | |
| B cell | 9 studies | 21% ± 4% | |
| memory B cell | 9 studies | 22% ± 4% | |
| plasmablast | 8 studies | 36% ± 22% | |
| plasmacytoid dendritic cell | 8 studies | 25% ± 8% | |
| conventional dendritic cell | 5 studies | 27% ± 10% | |
| IgG plasma cell | 4 studies | 21% ± 5% | |
| epithelial cell | 4 studies | 26% ± 9% | |
| myeloid cell | 4 studies | 23% ± 6% | |
| classical monocyte | 3 studies | 21% ± 3% | |
| hematopoietic precursor cell | 3 studies | 18% ± 1% | |
| non-classical monocyte | 3 studies | 24% ± 6% | |
| precursor B cell | 3 studies | 17% ± 2% | |
| dendritic cell | 3 studies | 47% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 2135.78 | 578 / 578 | 100% | 79.40 | 1155 / 1155 |
| pancreas | 100% | 1464.21 | 328 / 328 | 100% | 55.87 | 178 / 178 |
| uterus | 100% | 1977.04 | 170 / 170 | 100% | 76.37 | 459 / 459 |
| breast | 100% | 2012.63 | 459 / 459 | 100% | 84.45 | 1117 / 1118 |
| stomach | 100% | 1752.04 | 359 / 359 | 100% | 53.21 | 285 / 286 |
| intestine | 100% | 2215.14 | 966 / 966 | 100% | 59.12 | 525 / 527 |
| ovary | 100% | 1752.20 | 180 / 180 | 100% | 40.13 | 428 / 430 |
| thymus | 100% | 1957.55 | 653 / 653 | 100% | 45.44 | 602 / 605 |
| prostate | 100% | 2056.98 | 245 / 245 | 99% | 48.46 | 499 / 502 |
| bladder | 100% | 1877.57 | 21 / 21 | 99% | 69.98 | 500 / 504 |
| esophagus | 100% | 1673.14 | 1445 / 1445 | 99% | 39.93 | 181 / 183 |
| brain | 99% | 954.12 | 2611 / 2642 | 100% | 44.66 | 705 / 705 |
| kidney | 100% | 1690.38 | 89 / 89 | 99% | 36.62 | 888 / 901 |
| liver | 100% | 1480.84 | 225 / 226 | 97% | 50.23 | 394 / 406 |
| skin | 100% | 1950.68 | 1809 / 1809 | 96% | 48.00 | 455 / 472 |
| adrenal gland | 100% | 1873.57 | 258 / 258 | 90% | 32.86 | 208 / 230 |
| adipose | 100% | 1927.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 158.10 | 29 / 29 |
| spleen | 100% | 4527.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 68.84 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 70.56 | 1 / 1 |
| blood vessel | 100% | 1514.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1769.39 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 972.15 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1931.46 | 899 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 32.10 | 76 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | TOR3A |
| Protein name | Torsin family 3 member A Torsin-3A (ATP-dependent interferon-responsive protein) (Torsin family 3 member A) Epididymis secretory sperm binding protein (Torsin family 3, member A, isoform CRA_b) |
| Synonyms | ADIR hCG_23563 |
| Description | |
| Accessions | Q5W0C6 A0A024R943 Q9H497 ENST00000367625.8 F2Z3J4 ENST00000367627.8 [Q9H497-1] ENST00000352445.10 [Q9H497-2] ENST00000483887.1 ENST00000447595.1 Q5W0C9 |